SCHEMBL3462389

SCHEMBL3462389

COc1cc(OC(=O)Cl)c([N+](=O)[O-])cc1OC

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
KDM4E B2RXH2 3/20 0.50
CYP3A4 P08684 2/20 0.50
MAPT P10636 2/20 0.50
ALOX15 P16050 1/20 0.50
PRKDC P78527 1/20 0.50
HSD17B10 Q99714 1/20 0.50
LMNA P02545 1/20 0.49
HTT P42858 2/20 0.46
POLB P06746 1/20 0.46
NPC1 O15118 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
RAB9A P51151 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
TTR P02766 1/20 0.44
TDP1 Q9NUW8 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7158694 0.85 TNFSF11 (0.56) ALDH1A1KDM4ECYP3A4MAPTALOX15
SCHEMBL2042498 0.83 ALDH1A1 (0.50) ALDH1A1KDM4ECYP3A4MAPTALOX15
SCHEMBL30661876 0.83 ALDH1A1 (0.50) ALDH1A1KDM4ECYP3A4MAPTALOX15
SCHEMBL2087809 0.82 ALDH1A1 (0.63) ALDH1A1KDM4ECYP3A4MAPTALOX15
SCHEMBL27468061 0.81 VCP (0.54) ALDH1A1KDM4ECYP3A4MAPTALOX15
SCHEMBL10019210 0.81 POLB (0.50) ALDH1A1KDM4ECYP3A4MAPTALOX15
SCHEMBL29082090 0.81 ALDH1A1 (0.47) ALDH1A1KDM4ECYP3A4MAPTALOX15
SCHEMBL27512814 0.81 ALDH1A1 (0.47) ALDH1A1KDM4ECYP3A4MAPTALOX15
SCHEMBL13041058 0.80 MAPT (0.53) ALDH1A1KDM4EMAPTLMNANPC1
SCHEMBL15328150 0.78 TNFSF11 (0.51) ALDH1A1KDM4ECYP3A4MAPTALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1833987-A4 A SINGLE-STEP PLATFORM FOR ON-CHIP INTEGRATION OF BIO-MOLECULES YEDA RES & DEV (IL) 2009-03-11 EP claimed
EP-1833987-A2 A SINGLE-STEP PLATFORM FOR ON-CHIP INTEGRATION OF BIO-MOLECULES Yeda Research and Development Co. Ltd. at The Weizmann Institute of Science (IL) 2007-09-19 EP claimed
WO-2006064505-A2 A SINGLE-STEP PLATFORM FOR ON-CHIP INTEGRATION OF BIO-MOLECULES YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2006-06-22 WO claimed
WO-2021150844-A1 COMPOSITIONS CONTAINING 1,1-DISUBSTITUTED ACTIVATED ALKENES USEFUL IN ADDITIVE MANUFACTURING AND ARTICLES FORMED THEREFROM SIRRUS, INC. (US) 2021-07-29 WO disclosed
US-8679776-B2 Activatable dyes UNIVERSITY OF MASSACHUSETTS (US) 2014-03-25 US disclosed
EP-1833987-B1 A SINGLE-STEP PLATFORM FOR ON-CHIP INTEGRATION OF BIO-MOLECULES YEDA RES & DEV (IL) 2012-08-08 EP disclosed
US-20100297684-A1 ACTIVATIBLE DYES UNIVERSITY OF MASSACHUSETTS 2010-11-25 US disclosed
US-20100112569-A1 MICROFLUIDIC DEVICES AND METHODS OF GENERATING AND USING SAME YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2010-05-06 US disclosed
US-20100056392-A1 MICROSTRUCTURE AND MICRODOMAIN MICROARRAYS, METHODS OF MAKING SAME AND USES THEREOF ENERGY, UNITED STATES DEPARTMENT OF 2010-03-04 US disclosed
WO-2009036351-A2 ACTIVATIBLE DYES UNIVERSITY OF MASSACHUSETTS (US) 2009-03-19 WO disclosed
EP-1833987-A4 A SINGLE-STEP PLATFORM FOR ON-CHIP INTEGRATION OF BIO-MOLECULES YEDA RES & DEV (IL) 2009-03-11 EP disclosed
US-20030235851-A1 Fusion proteins; combinatorial libraries NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-12-25 US disclosed
WO-2003089454-A2 UNNATURAL AMINO ACID CONTAINING DISPLAY LIBRARIES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2003-10-30 WO disclosed
US-5556961-A Nucleosides with 5'-O-photolabile protecting groups AFFYMETRIX, INC. 1996-09-17 US disclosed
US-5482867-A Spatially-addressable immobilization of anti-ligands on surfaces AFFYMAX TECHNOLOGIES N.V. (NL) 1996-01-09 US disclosed
US-5451683-A Spatially-addressable immobilization of anti-ligands on surfaces AFFYMAX TECHNOLOGIES N.V. 1995-09-19 US disclosed
US-5252743-A Using cage binding compound AFFYMAX TECHNOLOGIES N.V. (NL) 1993-10-12 US disclosed
EP-0502060-A4 SPATIALLY-ADDRESSABLE IMMOBILIZATION OF ANTI-LIGANDS ON SURFACES 1993-05-05 EP disclosed
EP-0502060-A1 SPATIALLY-ADDRESSABLE IMMOBILIZATION OF ANTI-LIGANDS ON SURFACES AFFYMAX TECHNOLOGIES N.V. (AN) 1992-09-09 EP disclosed
WO-1991007087-A1 SPATIALLY-ADDRESSABLE IMMOBILIZATION OF ANTI-LIGANDS ON SURFACES AFFYMAX TECHNOLOGIES N.V. (AN) 1991-05-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297684-A1 ACTIVATIBLE DYES IK, MB, HMBS ALDH1A1 856/4885KDM4E 3095/4885CYP3A4 2277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.